I think its a very good thing bta's down on such low volume. very few are abandoning ship. Instos holding, top 20 holding. I would say the bta directors who bought not long ago know a lot more than we do re: orders, production and when the dispute with gsk is likely to be settled.
such poor interest provides us with another great buying opp.
